Suchergebnisse - "Lee, Sharen"

PubPharm (7)

1

Numbers Needed to Treat for Preventing Adverse Cardiovascular Outcomes for Sodium-Glucose Cotransporter 2 Inhibitors vs. Dipeptidyl Peptidase 4 Inhibitors : The Hong Kong Diabetes Study

enthalten in: Cardiovascular drugs and therapy | 2024

von Tse, G. | Lee, S. | Liu, T. | +1

2

Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression : a propensity score-matched study in Hong Kong

enthalten in: Acta diabetologica | 2023

von Mui, J. | Li, L. | Chou, O. | +6

3

Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients : A Propensity Score-Matched Study in Hong Kong

enthalten in: Cardiovascular drugs and therapy | 2023

von Lee, S. | Zhou, J. | Leung, K. | +10

CommentIn: Cardiovasc Drugs Ther. 2023 Aug;37(4):619-620. - PMID 36018479

4

Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in Type 2 diabetes mellitus : A population-based study

enthalten in: Cancer medicine | 2023

von Chung, C. | Lakhani, I. | Chou, O. | +10

5

Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes

enthalten in: Rheumatology (Oxford, England) | 2023

von Zhou, J. | Liu, X. | Chou, O. | +9

6

Lower risks of incident colorectal cancer in SGLT2i users compared to DPP4i users : A propensity score-matched study with competing risk analysis

enthalten in: European journal of internal medicine | 2023

von Chan, R. | Chan, R. | Chou, O. | +2

7

Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users

enthalten in: ESC heart failure | 2022

von Zhou, J. | Lee, S. | Leung, K. | +9

1
[1]